Our findings suggest that the status of EGFR mutations in male NSCLC patients negatively correlated with pSUVmax, CYFRA21-1 and SCC-Ag, and that a combination of these factors resulted in higher identification of EGFR mutation status in NSCLC patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.